Tuesday, April 16, 2024
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine
Division of Cardiovascular Medicine
SUNY Downstate Medical Center
Brooklyn, New York, United States
Professor of Vascular Medicine
Université Paris-Descartes
Hôpital Européen Georges-Pompidou
Hypertension Department
Paris, France
Associate Professor
Department of Internal Medicine
University of Nevada School of Medicine
Medical Director of Vascular Care
Renown Heart and Vascular Institute
Reno, Nevada, United States
Associate Professor
Harvard Medical School
Endocrinology, Diabetes and Hypertension
Brigham and Women’s Hospital
Director
Hypertension Service and Hypertension Specialty Clinic
Boston, Massachusetts, United States
Professor of Medicine
Chief Academic Officer, Center for Interventional Vascular Therapy
Director, NYP/Columbia Cardiac Catheterization Laboratories Columbia University College of Physicians and Surgeons
New York-Presbyterian Hospital
New York, New York, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for cardiologists, nephrologists, and primary care physicians.
The goal of this activity is that learners will be better able to understand the efficacy and safety as well as the prospective role of renal denervation in the management of patients with uncontrolled hypertension.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine
Division of Cardiovascular Medicine
SUNY Downstate Medical Center
Brooklyn, New York, United States
Professor of Vascular Medicine
Université Paris-Descartes
Hôpital Européen Georges-Pompidou
Hypertension Department
Paris, France
Associate Professor
Department of Internal Medicine
University of Nevada School of Medicine
Medical Director of Vascular Care
Renown Heart and Vascular Institute
Reno, Nevada, United States
Associate Professor
Harvard Medical School
Endocrinology, Diabetes and Hypertension
Brigham and Women’s Hospital
Director
Hypertension Service and Hypertension Specialty Clinic
Boston, Massachusetts, United States
Professor of Medicine
Chief Academic Officer, Center for Interventional Vascular Therapy
Director, NYP/Columbia Cardiac Catheterization Laboratories Columbia University College of Physicians and Surgeons
New York-Presbyterian Hospital
New York, New York, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 9/29/2022
Valid for credit through: 9/29/2023, 11:59 PM EST
processing....
All sections of this activity are required for credit.
Please answer these questions to complement your learning experience.
